Welcome to our dedicated page for Marchex news (Ticker: MCHX), a resource for investors and traders seeking the latest updates and insights on Marchex stock.
Marchex, Inc. develops AI-powered conversational intelligence and analytics solutions that turn customer communications into operating, sales, marketing, and service insights. The company focuses on B2B2C vertical markets, including automotive, home services, healthcare, real estate, advertising, franchising, and multi-unit retail, and operates around conversational analytics and related solutions.
Marchex news commonly covers product availability and platform updates such as the Marchex Engage Platform, integrations for healthcare and automotive workflows, customer deployments, franchise and location-level performance analytics, and quarterly or annual financial results. Updates also address omnichannel conversation data, campaign attribution, lead handling, benchmarking, and operational performance tools for enterprise and distributed-location customers.
Marchex (NASDAQ: MCHX) announced the results of a joint tender offer with Edenbrook Capital for up to 10 million shares of its Class B common stock at $2.15 per share. The offer, which expired on October 7, 2020, was oversubscribed with 10,552,160 shares tendered. Marchex will accept 5 million shares for a total price of approximately $10.8 million. This acquisition represents about 25% of its Class B stock. Post-transaction, Marchex will have roughly 34.9 million shares outstanding.